Işık Sakine, Çağlayan-Sözmen Şule, Asilsoy Suna, Kılıçarslan Serdar Kamer, Anal Özden, Karaman Özkan, Uzuner Nevin
Departments of Pediatric Allergy and Immunology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey.
Departments of Pediatrics, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey.
Turk J Pediatr. 2018;60(1):50-55. doi: 10.24953/turkjped.2018.01.007.
Işık S, Çağlayan-Sözmen Ş, Asilsoy S, Kılıçarslan SK, Anal Ö, Karaman Ö, Uzuner N. Knowledge levels related to allergen specific immunotherapy and perspectives of parents whose children were diagnosed with asthma and/or allergic rhinitis in Turkey. Turk J Pediatr 2018; 60: 50-55. In the present study, we aimed to evaluate the knowledge levels and perspectives about allergen specific immunotherapy (ASI) of parents whose children were diagnosed with asthma and/or allergic rhinitis with positive skin prick test. The study was conducted between September 2014 and January 2015. Surveys that were filled by 198 parents were analyzed. One hundred-ninety-eight parents were included in the study; 42.9% of the parents had knowledge about ASI. Parents obtained information about the ASI from respectively pediatric allergy specialists (25.5%), relatives and friends (17.8%), media (12.9%), and pediatrician (8.2%). There is a strong association between educational level of the mother, atopy background of the family, the monthly per capita income, and having knowledge about the ASI. Multivariate regression analysis revealed that individuals with a monthly income higher than 2,000 TL were more likely to be aware of the ASI application (OR: 4.35, 95% CI: 1.13-16.71; p < 0.05). Eighty-nine percent of the parents stated that they would prefer the sublingual ASI instead of subcutaneous ASI because it is easy to use and its severe side effects risk is low. The awareness of the ASI is at high rates in our patient population.
伊希克·S、恰拉扬 - 索兹门·Ş、阿西尔索伊·S、基利恰尔斯兰·SK、阿纳尔·Ö、卡拉曼·Ö、乌祖纳·N。土耳其患有哮喘和/或过敏性鼻炎儿童的父母对变应原特异性免疫疗法的知识水平及看法。《土耳其儿科学杂志》2018年;60:50 - 55。在本研究中,我们旨在评估皮肤点刺试验呈阳性且被诊断为哮喘和/或过敏性鼻炎儿童的父母对变应原特异性免疫疗法(ASI)的知识水平及看法。该研究于2014年9月至2015年1月进行。对198名父母填写的调查问卷进行了分析。198名父母纳入研究;42.9%的父母了解ASI。父母分别从儿科过敏专科医生(25.5%)、亲戚和朋友(17.8%)、媒体(12.9%)以及儿科医生(8.2%)处获取有关ASI的信息。母亲的教育水平、家庭特应性背景、月人均收入与了解ASI之间存在密切关联。多因素回归分析显示,月收入高于2000土耳其里拉的个体更有可能知晓ASI的应用(比值比:4.35,95%置信区间:1.13 - 16.71;p < 0.05)。89%的父母表示他们更倾向于舌下含服ASI而非皮下注射ASI,因为其使用方便且严重副作用风险低。我们的患者群体对ASI的知晓率较高。